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Background: Acute respiratory distress syndrome (ARDS) can emerge from certain pathologies, such as sepsis, fat
embolism and leptospirosis, in which the levels of unesterified fatty acids are increased in the patient’s plasma. ARDS is
characterized by edema formation, and edema resolution occurs mainly due to the pneumocyte Na/K-ATPase activity.
As previously described, increased oleic acid (OA) plasma concentrations induce lung injury by interfering with sodium
transport. The first aim of this study was to develop a radioactivity-free assay to detect Na,K-ATPase activity ex vivo using
a model of OA-induced lung injury in mice. We also investigated the relationship between Na/K-ATPase inhibition and
OA-induced lung injury using ouabain-induced lung injury as a comparison, because of the well-described effect of
ouabain as a Na/K-ATPase inhibitor.
Methods: We developed a Na/K-ATPase assay based on the capture of non-radioactive Rb+ ions by mice lung tissue in
the absence or presence of ouabain, a specific Na/K-ATPase inhibitor. Rb+ incorporation into the lung was measured
by inductively coupled plasma-optical emission spectrometry (ICP-OES) after lung tissue mineralization. Na/K-ATPase
activity was considered as the difference between Rb+ incorporation in the absence and in the presence of ouabain.
Bronchoalveolar lavage fluid was collected for lung injury assessment. For this assessment, cell counting, lipid body
enumeration and lipid mediator concentrations were measured. Histological analyses were used to determinate lung
pathology. Whole body plethysmographic analysis was performed to assay lung function.
Results: The lung Na/K-ATPase activity of mice was completely inhibited by an OA dose of 10 μmol, an effect also
obtained with 10-3 μmol of ouabain, as demonstrated by the decreased Rb+ incorporation in the lungs. The same OA
dose induced lung edema and inflammation with cell influx, lipid body formation, and leukotriene B4 (LTB4) and
prostaglandin E2 (PGE2) production. Ouabain also induced lung inflammation, as detected by histological examinations.
As far as we know, this is the first time that ouabain-induced lung injury was shown. Both OA and ouabain induced
functional lung pathology in mice simultaneously with inhibition of the lung Na/K-ATPase activity.
Conclusions: We developed a new non-radioactive assay to quantified Na/K-ATPase in vivo. OA and ouabain inhibited
in vivo Na/K-ATPase activity in the lungs and induced lung injury. Our data reinforce the idea that Na/K-ATPase inhibitors
may worsen lung injury in specific pathological conditions.
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The first description of adult respiratory distress syn-
drome (ARDS) appeared in 1967 [1]. A less severe form
of ARDS is characterized by increased alveolus per-
meability [2]; however, according to the Berlin definition,
the term ALI is no longer used, and ARDS can be stra-
tified into mild, moderate and severe [3]. Further im-
provements in the Berlin definition have already been
proposed [4]. The initial lesion in ARDS is an increase
in the alveolar capillary permeability to plasma proteins,
which leads to an interstitial and alveolar edema [3,5].
The resolution of pulmonary edema and of lung inflam-
mation is a relevant factor for ARDS outcome [6]. Fluid
management is one of the most important measures that
has been shown to impact ARDS, and a dynamic moni-
toring of the lung fluid balance seems to influence cli-
nical outcomes [7]. The removal of an alveolar edema
depends on the vectorial transport of salt and water
across the alveolar epithelium, in part through api-
cally located sodium channels (ENaC), followed by its
extrusion into the lung interstitium via the basola-
terally located Na/K-ATPase [8-10], which in turn
drives the passive water flow toward the capillary net
through certain transcellular channels, the aquaporins
[10]. Thus, the direct epithelial cell injury and/or de-
fects in ion transport inflicted by bacterial and viral
pathogens or by oxidative injury lead to a reduction
in fluid clearance [11].
The acute inflammatory response in ARDS com-
promises the integrity of the alveolar-capillary mem-
brane. In this respect, OA can induce lung pathology
that is similar to clinical ARDS [12].
In the present work, we developed a Na/K-ATPase
assay based on non-radioactive Rb+ uptake by mouse
lung tissue 30 min after an intravenous (i.v.) injection of
OA, in the presence or absence of ouabain. In addition,
we used an in vivo mouse model of ARDS induced by
OA to evaluate edema formation, lung inflammation,




All experiments were conducted in male Swiss mice
(25 – 35 g) obtained from the Oswaldo Cruz Founda-
tion breeding unit. The animals were lodged at 22°C
with a 12 h light/dark cycle and free access to food
and water. Animal housing conditions and all expe-
rimental procedures conformed to institutional regu-
lations and were in accordance with the National
Institute of Health guidelines on animal care. The in-
stitutional animal welfare committee approved all of
the procedures described here under license number
002–08.Preparation of oleate solutions
OA (Sigma-Aldrich, St. Louis, MO) was used to prepare
a 100 mM tris-oleate solution as described in Gonçalves
de Albuquerque, 2012 [13]. Briefly, after weighting and
water addition, sodium hydroxide was slowly added
until the pH reached 12.0. The mixture was sonicated to
complete oleate solubility, and then, the pH was care-
fully adjusted to 7.6 with dilute Hydrochloric acid. The
working oleate solutions were prepared by appropriate
dilutions of the 100 mM solution with sterile saline
(PBS) pH 7.5. The working oleate solutions were tested
for the presence of LPS by the limulus amebocyte lysate
test (LAL), which was provided by the Instituto Nacional
de Controle de Qualidade em Saúde (INCQS)-Fundação
Oswaldo Cruz, and showed negative results.
Intravenous administration of oleate
Intravenous injections were administered into the orbital
plexus (inner angle of the eye ball). Each group received
100 μL of tris-oleate solution containing either 2.5, 5.0 or
10.0 μmol of OA per animal. Edema formation and in-
flammatory parameters were measured several times after
the challenge. Control groups received 100 μL of sterile
saline (PBS).
Na/K ATPase assay in mouse lungs based on
Rb+ incorporation
The mice were divided into 3 groups and anesthetized with
isoflurane. Each animal in the first group received 100 μL
of a KCl free-Hank’s solution containing 8 μmol RbCl and
2.0, 5.0 or 10.0 μmol of OA. The second group received the
same amount of RbCl and 10-3 μmol of ouabain per animal.
The third group (controls) received only 8 μmol of RbCl.
After 30 min, the animals were sacrificed with isoflurane,
and their lungs were removed, rinsed in cold PBS and cut
into small pieces. After the removal of excess liquid with fil-
ter paper, 0.5 g of the lung tissue was transferred to glass
tubes for mineralization. After 5 mL of 65% nitric acid was
added, the tubes were heated in a digesting plate (model
TE 040125 -Tecnal Ind.) until complete digestion. After
cooling, the volumes were standardized at 25 mL using dis-
tilled water. Mineralized tissue samples were used to quan-
tify the Rb+ [14]. Rb+ was quantified by inductively coupled
plasma optical emission spectrometry (ICP-OES) using an
Ultima 2 apparatus with Mira Mist Nebulizer and spray
chamber (Jobin Yvon, Longjumeau, France). A rubidium
nitrate standard (Ultra Scientific, EUA) was used to con-
struct the calibration curve. The results were expressed in
μmol of Rb+ incorporated per 30 min per gram of tissue.
Total and differential cell analysis and total protein assay
of bronchoalveolar lavage fluid (BALF)
Bronchoalveolar lavage was performed after the trachea
was isolated by blunt dissection. A small caliber tube
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PBS were sequentially instilled, gently aspirated and
pooled. In every instillation/aspiration cycle, the same
volume (1.0 mL) was recovered from each animal. Total
leukocyte counts were performed by optical microscopy
in Neubauer chambers after diluting BALF samples in
Türk solution (2% acetic acid). Differential leukocyte
counts were determined in cytocentrifuged smears stained
by the May-Grunwald-Giemsa method. The BALF total
protein in the supernatant was determined by the Micron
BCA Kit method (Pierce) according to the manufacturer’s
instructions.
Lipid body staining and counting
While still moist, the leukocytes on the cytospin slides
were fixed in 3.7% formaldehyde in Ca2 + −, Mg2+ -
free HBSS medium (pH 7.4) and stained with 1.5%Figure 1 Inhibition of Rb+ incorporation into lung tissue by OA and o
experimental groups, 2.5, 5 and 10 μmol of OA; 10-3 or 10-4 μmol of ouabain;
together with 8 μmol Rb+. Rb+ incorporation in lungs was measured after 30
μmol Rb+ incorporated per h per g of wet tissue ± SEM of 6 to 15 animals in
data from Figure 1A (the difference between Rb+ incorporation in absence an
*P < 0.0001, compared to controls.OsO4, as described by Bozza [15]. Lipid bodies were
enumerated by light microscopy with oil-immersion
objective lens in 50 consecutively scanned leukocytes.
Leukotriene B4 (LTB4) and Prostaglandin E2 (PGE2)
LTB4 and PGE2 in the BALF supernatants were assayed
by EIA kits according to the manufacturer’s instructions
(Cayman Chemical, Ann Arbor, Mi).
Morphological studies
We euthanized the animals using a CO2 chamber
30 minutes or 24 h after the intravenous injection of
OA, ouabain or sterile saline. The lungs were removed
and then fixed in 3.7% neutral buffered formalin, em-
bedded in paraffin, sectioned into 4 μm samples and
stained with hematoxylin and eosin. Macroscopic pho-
tos were taken after the lung had been removed.uabain. (A) Control group was treated solely with 8 μmol Rb+. In the
or 10-4 μmol ouabain plus OA 5 μmol were injected by the i.v. route
min by ICP-OES in mineralized lung tissues. The results are expressed in
each group. (B) Calculated percent inhibition of Na/K-ATPase based on
d in presence of ouabain was considered as 100% enzyme activity).
Table 1 Inhibition of the Rb+ incorporation in the lung
tissue and NKA inhibition by 10 μmol of oleic acid
% of total Rb+ uptake and NKA
Parameter analyzed Inhibition by 10 μmol of OA
Time 30 min 6 h 24 h
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These evaluations were performed on unrestrained ani-
mals, individually, 24 hours after the challenge by barome-
tric plethysmography with a whole body plethysmograph
(WBP, Buxco, Troy, NY), as previously described [16].Inhibition of total Rubidium uptake 36% 25.8% 21%
Ouabain-sensitive NKA inhibition* 100% 71.8% 63.8%
*OA inhibited Rb+ incorporation just as ouabain did (10-3 μmol) after 30 min.
This was considered to be total NKA inhibition.Statistical analysis
The results were expressed as the means ± SEM and were
analyzed with One-way Anova followed by the Neuman-
Keuls-Student test. Differences were considered significant
at p < 0.05.Results
The evaluation of the Na/K-ATPase activity in lung cells
was performed by a single injection of Rb+ or Rb+ plus
OA and then measuring the Rb+ incorporation into the
lung tissue after discounting the basal contamination
obtained by inoculating 10-3 μmol of ouabain. Figure 1A
shows the Rb+ incorporation by the lung tissue 30 minutes
after its inoculation, as well as the different doses of OA
or ouabain or ouabain plus OA. Figure 1B displays the
calculated Na/K-ATPase inhibition curve obtained from
the data of Figure 1A. We also measured the Rb+ incor-
poration at 6 and 24 h after the challenge (Figure 2).
Table 1 shows the percentage of Rb+ incorporation after a
10 μmol OA injection. OA inhibition, either of the total
amount or ouabain-sensitive Rb+ incorporation, was
greater at 30 min but remained significant until 24 hFigure 2 Inhibition of Rb+ incorporation into lung tissue by OA
at 6 and 24 h. Control group was treated solely with 8 μmol Rb+,
and 10 μmol of OA was injected by the i.v. route. After 5 h and
30 min or 23 h and 30 min, the animals were injected with 8 μmol
Rb+. Rb+ incorporation in lungs was measured 6 or 24 h after the
OA challenge by ICP-OES in mineralized lung tissues. The results are
expressed in μmol Rb+ incorporated per h per g of wet tissue ± SEM
of 6 to 21 animals in each group.
Figure 3 Cell accumulation and total protein content in BALF 6,
24 and 48 h after OA injection. Mononuclear cells (A), neutrophils
(B) and total protein (C). Control group received the same volume of
sterile saline. OA (dark columns) was injected i.v. at 10 μmol. The
results are means ± SEM from at least 3 different experiments. Each
point in an experiment is the mean of 7 different animals. *P < 0.0001,
compared to controls.
Figure 4 Lipid body formation in leukocytes and leukotriene B4 and PGE2 production in BALF of OA treated mice. Animals received
10 μmol OA by i.v. injection (dark columns). Lipid bodies at 6 h (A) and 24 h (B) after the OA injection were enumerated in 50 consecutive cells
in osmium-stained cytocentrifuged smears; LTB4 (C) at 6 h and PGE2 (D) at 24 h after OA challenge were determined in the BALF by ELISA. The
control group received sterile saline. The results are means ± SEM of 6 animals in each group. *P < 0.001, compared to controls.
Figure 5 Total protein in BALF 24 h after ouabain injection. The
control group received the same volume of sterile saline. Ouabain
was injected i.v. at 10-3 μmol, 10-4 μmol or at 10-3 μmol plus OA
5 μmol. The results are means ± SEM from at least 6 animals in each
group. *P < 0.05, compared to controls.
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injection was characterized by measurements of protein
extravasation, leucocyte migration, lipid body formation
in leucocytes and PGE2 and LTB4 production, which
were used as markers of lung edema and inflammation
in BALF samples. Increased cell migration was detected
after 6 hours, but a higher neutrophil infiltration oc-
curred at 24 h after OA administration, returning to
basal levels at 48 h (Figures 3A and 3B). Lung edema
formation, which was evaluated by assaying the total
proteins in the BALF supernatants, occurred as early as
6 h but was less intense at 24 h before returning to basal
levels at 48 h (Figure 3C).
Lipid bodies produce lipid mediators that can be used
as markers of cell activation. These markers increased at
6 h and reached a peak at 24 h after the OA treatment
(Figure 4A and 4B). The lipid mediator LTB4 was ele-
vated at 6 h (Figure 4C), while PGE2 was markedly aug-
mented 24 h after OA treatment (Figure 4D).
As edema formation is a characteristic of ARDS, we
also measured the protein content in BALF after dif-
ferent doses of ouabain and ouabain plus OA in 24 h
(Figure 5). All doses tested caused an increase in the
total protein in the BALF, but they did not induce cell
accumulation in the BALF at this time point.
Macroscopic examination of mice lungs injected with
ouabain or OA revealed congestion and hemorrhagic
areas at 30 min (Figure 6) that were also detected at
A B C
Figure 6 Illustrative macroscopic examination of lungs after OA or ouabain challenge. Macroscopic photos of mice lungs challenged with
sterile saline (A) ouabain 10 -3 μmol/ (B), or OA 10 μmol (C). Green arrows point to hemorrhagic points, and blue circles delimitate large
hemorrhagic areas.
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examinations of the lungs 30 min and 24 h after the
challenge with OA, ouabain or ouabain plus OA. To
quantify the extent of the lung injury, we adapted a
scoring system that takes into account intra-alveolar
hemorrhage, leukocyte infiltration and tissue disruption
[17]. Table 2 demonstrates that OA and ouabain signifi-
cantly increased lung injury scores, although the effect
was more pronounced with OA. The administration of
OA plus ouabain did not have an additive effect because
the lung injury scores were similar to the ones observed
with OA alone. These results are illustrated in Figures 7
and Figure 8 for the 30 min and 24 h time point ana-
lysis, respectively. Hemorrhagic points, leukocytes in
the lung tissue and some tissue disruption can be clearly
detected after OA or ouabain injury, but, as mentioned
above, the effect was more pronounced in the OA-
challenged mice. Lung function was also evaluated by
whole body plethysmography 30 min after OA or ouabain.
Compared to controls, both OA and ouabain mice had
significantly increased enhanced breathing pauses (Penh),
which was used as an index of airway obstruction (from
0.58 ±0.69 in controls to 1.25 ± 0.34 in ouabain-injected
mice and 0.87 ± 0.12 in OA-injected mice).
Discussion
The doses of oleic acid inhibited Rb+ uptake by the lung
tissue, as did the 10-3 μmol dose of ouabain, a classical
Na/K-ATPase inhibitor. We assume that this ouabain
dose completely blocked the rubidium incorporation
associated with the Na/K-ATPase activity because higher
doses killed the majority of the animals. Lower ouabainTable 2 Lung injury score extension based on histological an
Control Ouabain 10-4 μmol
*Lung injury score 30 min - +
*Lung injury score 24 h - +
* Lung injury scores take into account the intra-alveolar hemorrhage, leukocyte infiltra
the symbols + to +++++ represent mild to severe lung injury.doses or ouabain plus OA had similar effects on Rb+ tissue
incorporation. The somewhat high ouabain-insensitive
Rb+ measurement can be attributed not only to an incom-
plete tissue-washing procedure but also to a passive Rb+
incorporation through K+ channels. The proposed in vivo
Na/K-ATPase assay has low costs and high reliability and
represents an adaptation of the mouse lung assessment
method of our previous report, which measured liver
Na/K-ATPase activity through a liver perfusion metho-
dology in rats [14].
We chose a model of OA-induced ARDS in mice be-
cause the mouse is an extensively used model that remains
relevant in the study of lung injury mechanisms. More-
over, inflammation induced by the intravenous adminis-
tration of OA resembles ARDS in many morphological,
histological and physiological aspects [18]. In this regard,
ARDS patients or at-risk patients who subsequently de-
velop ARDS have increased plasma OA concentrations
[19]. Sepsis patients could develop ARDS [20], as they also
present markedly increased plasma OA levels compared
to healthy volunteers [21]. Previous work has shown that
OA is an endogenous Na/K-ATPase inhibitor [22]. Fur-
thermore, OA was able to inhibit Na/K-ATPase in an
ARDS rabbit model, resulting in a significantly increased
endothelial permeability [23,24]. In most ARDS patients,
the edema resolution and Na,K-ATPase activity are im-
paired and only patients with reduced edema clearance
have a higher mortality [8,25,26] suggesting that Na,
K-ATPase is an important player in the pathophysiology
of ARDS.
Leukocyte recruitment is essential to the immune
response to an injury or an infection [27]. In ARDS,alysis
Ouabain 10-3 μmol OA OA + Ouabain 10-3 μmol
++ +++++ +++++
+ ++++ ++++













Ouabain 10-4 µmol Ouabain 10-3 µmol
Figure 7 Illustrative microphotographs of lung pathology caused by OA and ouabain at 30 min. Sterile saline (control – A, D); ouabain
10-4 (B, E), or 10-3 μmol (C, F); OA 10 μmol (G, I) or OA 10 μmol + ouabain 10-3 μmol (H, J) were injected i.v. 30 min before the collection of the
lungs. Figures are shown at 100× magnification (A, B, C, G, H) or 1000× magnification (D, E, F, I, J). These pictures are representative of at least 5
animals in each group.
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Activated neutrophils release an arsenal of potent mole-
cules and contribute to increased tissue damage and
inflammation [29]. Whether neutrophil infiltration is the
cause or the consequence of the injury is still debatable
because ARDS may develop in patients with neutropenia
[5]. We detected an increase in total cell accumulation
in the BALF (mainly neutrophils), which was consistent
with an ARDS type of reaction induced by OA.
Lipid bodies are cytoplasmic inclusions that are present
in different cellular types [30]; they increase in number
and size in cells involved in inflammatory and immu-
nologic processes [31]. In our experiments, oleic acid
induced lipid body formation in leukocytes, denotingcellular activation [32]. These structures are rich in
enzymes and substrates, generating lipid mediators such
as LTB4 (a potent chemotactic agent to neutrophils) and
PGE2 [15], inducing cell migration and increasing endo-
thelial permeability. It has already been described that
OA-induced ALI increased plasma PGE2 levels [33]. The
crosstalk of intracellular pathways with lipid body forma-
tion could stem from OA signaling, including inflamma-
some activation by the low intracellular concentration of
K+ due to pump inhibition [34]. However, this activation
could also involve the role of this enzyme in other signal
transduction pathways [35]. Leukotrienes, including LTB4,
were not likely to be relevant mediators involved in patho-











OA 10 µmol OA 10 µmol + ouabain 10-3
µmol
Figure 8 Illustrative microphotographs of lung pathology caused by OA and ouabain at 24 h. Sterile saline (control – A, D); ouabain 10-4
(B, E), or 10-3 μmol (C, F); OA 10 μmol (G, I) or OA 10 μmol + ouabain 10-3 μmol (H, J) were injected i.v. 24 h before the collection of the lungs.
Figures are shown at 100× magnification (A, B, C, G, H) or 1000× magnification (D, E, F, I, J). These pictures are representative of at least 5
animals in each group.
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similar to the increase observed in rats [37]. These obser-
vations might indicate the existence of species-specific
effects of OA. Importantly, the rise of LTB4 and PGE2 in
human samples preceded ARDS in injured blunt-trauma
patients [38]. Similarly, in our model, OA augmented
BALF PGE2, suggesting that it is suited for comparison
with the clinical situation.
Oleic acid-induced Na/K-ATPase inhibition persists
until 24 h after the challenge, suggesting that this me-
chanism may be an important contributor to lung injury.
The fact that ouabain-induced lung injury was similar tothat induced by OA, but less severe, may indicate that
OA has additional mechanisms of injury beyond the in-
hibition of the Na/K ATPAse. As the Na/K-ATPase is
the sole biological target known for ouabain, this obser-
vation reinforces the claim that OA may have additional
biological targets contributing to lung injury, as dis-
cussed above. Nevertheless, lung injury demonstrates a
nice correlation with Na/K-ATPase inhibition, both at
30 min and 24 h after the challenge, suggesting a poten-
tial causal effect. that oleic acid can cause lung injury
with alveoli disruption has been well characterized in
animal models [39] and may contribute to the lower Rb+
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observed macroscopically, and we demonstrated func-
tional repercussions with either ouabain or OA.
As a corollary, patients with high levels of plasma OA
have a higher risk of developing ARDS [19] or showing
deleterious effects on their heart muscle [40]. Therefore,
we can suggest that lowering OA plasma levels could
help in the prevention of the high mortality and morbi-
dity of ARDS.
Conclusion
In conclusion, we developed a new, non-radioactive assay
to quantify Na/K-ATPase in vivo. The inhibition of the
Na/K-ATPase in vivo by either OA- or ouabain-induced
lung injury in mice. Our data reinforce the idea that
Na/K-ATPase inhibition by OA seems to play a relevant
role in lung injury during conditions of high plasma
OA levels, such sepsis, leptospirosis, pancreatitis and
eclampsia.Abbreviations
ARDS: Acute respiratory distress syndrome; Na/K-ATPase: Sodium potassium
ATPase pump; OA: Oleic acid (18:1n-9); ICP-OES: Coupled plasma-optical
emission spectrometry; ENaC: Epithelial apically located sodium channel;
LAL: Limulus amebocyte lysate test; BALF: Bronchoalveolar lavage fluid.Competing interests
The authors state that they have no conflicts of interest to disclose.Authors’ contributions
CFGA – Conception and design of the experiments; participation in the
manuscript drafting and direct participation in the experiments. PB –
Performance of the Na/K-ATPase experiments based on Rb+ incorporation.
ARS – Performance of the animal manipulations and aid in drafting the
manuscript. IMMM and FMJO – Participation in the animal experiments.
PTB – In charge of the lipid bodies and of the design of the lipid mediator
experiments. RES and ASF – Performance of data acquisition and analysis of
the Na/K-ATPase results on Rb+ incorporation. MYI – Participation in the
experimental design and in manuscript drafting. HCCFN- Conception of the
study, participation in its design and aid in drafting the manuscript. MVCF-
Participation in the manuscript drafting and approval of the final version of
the manuscript. All authors read and approved the final manuscript.Acknowledgements
This work received financial support from Fundação de Amparo a Pesquisa
do Estado do Rio de Janeiro (FAPERJ), Programa Estratégico de Apoio à
Pesquisa em Saúde (PAPES)-FIOCRUZ and Conselho Nacional de
Desenvolvimento Científico e Tecnológico (CNPq). We acknowledge the
institutions where this work was accomplished, as follows: Fundação
Oswaldo Cruz (FIOCRUZ), Universidade do Estado do Rio de Janeiro (UERJ)
and Universidade Federal Fluminense (UFF).
Author details
1Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, Fiocruz, Rio de
Janeiro, RJ, Brazil. 2Departamento de Biologia Celular e Molecular, Instituto de
Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil. 3Departamento
de Química Analítica, Universidade Federal do Rio de Janeiro, Rio de Janeiro,
RJ, Brazil. 4Departamento de Medicina Interna, Faculdade de Ciências
Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Received: 8 October 2012 Accepted: 28 October 2013
Published: 31 October 2013References
1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress
in adults. Lancet 1967, 2:319–323.
2. Wang HM, Bodenstein M, Markstaller K: Overview of the pathology of
three widely used animal models of acute lung injury. Eur Surg Res 2008,
40:305–316.
3. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin
definition. JAMA 2012, 307:2526–2533.
4. Costa EL, Amato MB: The new definition for acute lung injury and acute
respiratory distress syndrome: is there room for improvement? Curr Opin
Crit Care 2013, 19:16–23.
5. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J
Med 2000, 342:1334–1349.
6. Pierrakos C, Karanikolas M, Scolletta S, Karamouzos K, Velissaris D: Acute
respiratory distress syndrome: pathophysiology and therapeutic options.
J Clin Med Res 2012, 4:7–16.
7. Neamu RF, Martin GS: Fluid management in acute respiratory distress
syndrome. Curr Opin Crit Care 2013, 19:24–30.
8. Sznajder JI, Factor P, Ingbar DH: Invited review: lung edema clearance:
role of Na(+)-K(+)-ATPase. J Appl Physiol 2002, 93:1860–1866.
9. Vadasz I, Morty RE, Olschewski A, Konigshoff M, Kohstall MG, Ghofrani HA,
Grimminger F, Seeger W: Thrombin impairs alveolar fluid clearance by
promoting endocytosis of Na+, K + −ATPase. Am J Respir Cell Mol Biol
2005, 33:343–354.
10. Matthay MA, Folkesson HG, Clerici C: Lung epithelial fluid transport and
the resolution of pulmonary edema. Physiol Rev 2002, 82:569–600.
11. Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory
distress syndrome: four decades of inquiry into pathogenesis and
rational management. Am J Respir Cell Mol Biol 2005, 33:319–327.
12. Ballard-Croft C, Wang D, Sumpter LR, Zhou X, Zwischenberger JB:
Large-animal models of acute respiratory distress syndrome. Ann Thorac
Surg 2012, 93:1331–1339.
13. de Albuquerque CF G, Burth P, Younes Ibrahim M, Garcia DG, Bozza PT,
Castro Faria Neto HC, Castro Faria MV: Reduced plasma nonesterified fatty
acid levels and the advent of an acute lung injury in mice after
intravenous or enteral oleic acid administration. Mediators Inflamm 2012,
2012:601032.
14. Dos Santos MC, Burth P, Younes-Ibrahim M, Goncalves CF, Santelli RE,
Oliveira EP, de Castro Faria MV: Na/K-ATPase assay in the intact guinea
pig liver submitted to in situ perfusion. Anal Biochem 2009,
385:65–68.
15. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF:
Leukocyte lipid body formation and eicosanoid generation:
cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci USA
1996, 93:11091–11096.
16. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG,
Gelfand EW: Noninvasive measurement of airway responsiveness in
allergic mice using barometric plethysmography. Am J Respir Crit Care
Med 1997, 156:766–775.
17. Murao Y, Loomis W, Wolf P, Hoyt DB, Junger WG: Effect of dose of
hypertonic saline on its potential to prevent lung tissue damage in a
mouse model of hemorrhagic shock. Shock 2003, 20:29–34.
18. Shuster DP: ARDS: clinical lessons from the oleic acid model of acute
injury. Am J Respir Crit Care Med 1994, 149:245–260.
19. Quinlan GJ, Lamb NJ, Evans TW, Gutteridge JM: Plasma fatty acid changes
and increased lipid peroxidation in patients with adult respiratory
distress syndrome. Crit Care Med 1996, 24:241–246.
20. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress
syndrome. J Clin Invest 2012, 122:2731–2740.
21. Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, Seeger W,
Grimminger F: Parenteral nutrition with fish oil modulates cytokine
response in patients with sepsis. Am J Respir Crit Care Med 2003,
167:1321–1328.
22. Tamura M, Kuwano H, Kinoshita T, Inagami T: Identification of linoleic and
oleic acids as endogenous Na+, K + −ATPase inhibitors from acute
volume-expanded hog plasma. J Biol Chem 1985, 260:9672–9677.
23. Vadasz I, Morty RE, Kohstall MG, Olschewski A, Grimminger F, Seeger W,
Ghofrani HA: Oleic acid inhibits alveolar fluid reabsorption: a role in
acute respiratory distress syndrome? Am J Respir Crit Care Med 2005,
171:469–479.
Gonçalves-de-Albuquerque et al. Journal of Inflammation 2013, 10:34 Page 10 of 10
http://www.journal-inflammation.com/content/10/1/3424. Vadasz I, Raviv S, Sznajder JI: Alveolar epithelium and Na, K-ATPase in
acute lung injury. Intensive Care Med 2007, 33:1243–1251.
25. Sznajder JI: Alveolar edema must be cleared for the acute respiratory
distress syndrome patient to survive. Am J Respir Crit Care Med 2001,
163:1293–1294.
26. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority
of patients with acute lung injury and the acute respiratory distress
syndrome. Am J Respir Crit Care Med 2001, 163:1376–1383.
27. Kelly M, Hwang JM, Kubes P: Modulating leukocyte recruitment in
inflammation. J Allergy Clin Immunol 2007, 120:3–10.
28. Chen DL, Schuster DP: Positron emission tomography with [18 F]
fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung
injury. Am J Physiol Lung Cell Mol Physiol 2004, 286:L834–L840.
29. Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE: Endothelial
pathomechanisms in acute lung injury. Vascul Pharmacol 2008,
49:119–133.
30. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichtenstein LM, Weller PF:
Ultrastructural immunogold localization of prostaglandin endoperoxide
synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid
bodies in human lung mast cells, alveolar macrophages, type II
pneumocytes, and neutrophils. J Histochem Cytochem 1992, 40:759–769.
31. Bozza PT, Magalhaes KG, Weller PF: Leukocyte lipid bodies - Biogenesis
and functions in inflammation. Biochim Biophys Acta 2009, 1791:540–551.
32. Bozza PT, Yu W, Penrose JF, Morgan ES, Dvorak AM, Weller PF: Eosinophil
lipid bodies: specific, inducible intracellular sites for enhanced
eicosanoid formation. J Exp Med 1997, 186:909–920.
33. Hageman JR, McCulloch K, Hunt CE, Cobb M, Quade B, Crussi F, Pachman L:
Oleic acid lung injury increases plasma prostaglandin levels.
Prostaglandins Leukot Essent Fatty Acids 1989, 35:157–164.
34. Lacroix-Lamande S, D’Andon MF, Michel E, Ratet G, Philpott DJ, Girardin SE,
Boneca IG, Vandewalle A, Werts C: Downregulation of the Na/K-ATPase
pump by leptospiral glycolipoprotein activates the NLRP3
inflammasome. J Immunol 2012, 188:2805–2814.
35. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R:
Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys
Acta 2007, 1776:32–57.
36. Kruse-Elliott K, Olson NC: Role of leukotrienes during oleic acid-induced
lung injury in pigs. J Appl Physiol 1990, 68:1360–1367.
37. Ball HA, Cook JA, Spicer KM, Wise WC, Halushka PV: Essential fatty
acid-deficient rats are resistant to oleic acid-induced pulmonary injury.
J Appl Physiol 1989, 67:811–816.
38. Rivkind AI, Siegel JH, Guadalupi P, Littleton M: Sequential patterns of
eicosanoid, platelet, and neutrophil interactions in the evolution of the
fulminant post-traumatic adult respiratory distress syndrome.
Ann Surg 1989, 210:355–372. discussion 372–353.
39. Sun Y, Yang R, Zhong JG, Fang F, Jiang JJ, Liu MY, Lu J: Aerosolised
surfactant generated by a novel noninvasive apparatus reduced acute
lung injury in rats. Crit Care 2009, 13:R31.
40. Nogueira AC, Kawabata V, Biselli P, Lins MH, Valeri C, Seckler M, Hoshino W,
Junior LG, Bernik MM, de Andrade Machado JB, et al: Changes in plasma
free fatty acid levels in septic patients are associated with cardiac
damage and reduction in heart rate variability. Shock 2008, 29:342–348.
doi:10.1186/1476-9255-10-34
Cite this article as: Gonçalves-de-Albuquerque et al.: Oleic acid inhibits
lung Na/K-ATPase in mice and induces injury with lipid body formation
in leukocytes and eicosanoid production. Journal of Inflammation
2013 10:34.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
